Debt Financing

Cash-Burning Biotechs Turn to Debt to Help Chase Covid Cures

3 min readBiotech companies have taken center stage during the pandemic of 2020. Between the many vaccine initiatives and even more numerous investments in testing and new Covid-19 therapies, money is flooding into the sector at a record rate. Biotechs raised more than $6 billion in initial public offerings in just the first half of the year….

It’s Time to Take a Hard Look at Your Debt Covenants

2 min readJune 30th may be a day of reckoning for many early- and growth-stage companies with venture debt loan obligations. That’s a date when lenders schedule end-of-quarter “covenant testing” to ensure borrowers will continue to be able to make timely payments while using loans for their intended purposes. If you’ve taken on debt to extend your…

Why Good Deals Turn Bad in Early-Stage Debt Financing

2 min readAt Capital Advisors Group, we have advised hundreds of early-stage companies on billions of dollars of debt transactions over the past 17 years. We’ve learned that every deal is different, and every company’s capital structure is unique. But one thing never seems to change: even the best-laid plans can go awry. Over the years, we…